220 related articles for article (PubMed ID: 8080986)
1. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.
Correll PH; Colilla S; Karlsson S
Blood; 1994 Sep; 84(6):1812-22. PubMed ID: 8080986
[TBL] [Abstract][Full Text] [Related]
2. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells.
Correll PH; Colilla S; Dave HP; Karlsson S
Blood; 1992 Jul; 80(2):331-6. PubMed ID: 1627794
[TBL] [Abstract][Full Text] [Related]
3. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
4. Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.
Correll PH; Fink JK; Brady RO; Perry LK; Karlsson S
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8912-6. PubMed ID: 2573069
[TBL] [Abstract][Full Text] [Related]
5. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
[TBL] [Abstract][Full Text] [Related]
6. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
7. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients.
Medin JA; Migita M; Pawliuk R; Jacobson S; Amiri M; Kluepfel-Stahl S; Brady RO; Humphries RK; Karlsson S
Blood; 1996 Mar; 87(5):1754-62. PubMed ID: 8634421
[TBL] [Abstract][Full Text] [Related]
8. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors.
Migita M; Medin JA; Pawliuk R; Jacobson S; Nagle JW; Anderson S; Amiri M; Humphries RK; Karlsson S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12075-9. PubMed ID: 8618847
[TBL] [Abstract][Full Text] [Related]
9. Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer.
Nolta JA; Sender LS; Barranger JA; Kohn DB
Blood; 1990 Feb; 75(3):787-97. PubMed ID: 2297579
[TBL] [Abstract][Full Text] [Related]
10. Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells.
Correll PH; Kew Y; Perry LK; Brady RO; Fink JK; Karlsson S
Hum Gene Ther; 1990; 1(3):277-87. PubMed ID: 2081194
[TBL] [Abstract][Full Text] [Related]
11. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.
Challita PM; Kohn DB
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2567-71. PubMed ID: 8146155
[TBL] [Abstract][Full Text] [Related]
12. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
[TBL] [Abstract][Full Text] [Related]
13. Toward gene therapy for Gaucher disease.
Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
[TBL] [Abstract][Full Text] [Related]
14. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells.
Krall WJ; Skelton DC; Yu XJ; Riviere I; Lehn P; Mulligan RC; Kohn DB
Gene Ther; 1996 Jan; 3(1):37-48. PubMed ID: 8929910
[TBL] [Abstract][Full Text] [Related]
16. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells.
Weinthal J; Nolta JA; Yu XJ; Lilley J; Uribe L; Kohn DB
Bone Marrow Transplant; 1991 Nov; 8(5):403-12. PubMed ID: 1768976
[TBL] [Abstract][Full Text] [Related]
17. Introduction and expression of the interleukin 2 receptor (Tac) gene in hematopoietic stem cells with retrovirus vectors.
Takeda S; Hamaguchi Y; Zong SQ; Kuze K; Honjo T; Ishimoto M; Nakano T; Kitamura Y
Growth Factors; 1988; 1(1):59-66. PubMed ID: 3078565
[TBL] [Abstract][Full Text] [Related]
18. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Rivière I; Brose K; Mulligan RC
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6733-7. PubMed ID: 7624312
[TBL] [Abstract][Full Text] [Related]
19. Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression.
Apperley JF; Luskey BD; Williams DA
Blood; 1991 Jul; 78(2):310-7. PubMed ID: 2070069
[TBL] [Abstract][Full Text] [Related]
20. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.
Robbins PB; Skelton DC; Yu XJ; Halene S; Leonard EH; Kohn DB
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10182-7. PubMed ID: 9707621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
